2606004107
  • Open Access
  • Letter

Patient-Reported Adverse Reactions and Early Detection of Unresolved Interactions in a Canadian Dermatology Chatbot

  • Sepideh Emam 1,*,   
  • Robert Gniadecki 2

Received: 08 May 2026 | Revised: 30 May 2026 | Accepted: 02 Jun 2026 | Published: 24 Jun 2026

Abstract

Background: Dermatology chatbots are increasingly used for patient engagement and triage, generating large volumes of patient-reported data. Objective: To examine the nature of patient-reported adverse reactions and evaluate machine learning approaches for early detection of unresolved chatbot interactions. Methods: A dataset of 103 anonymized chatbot conversations was analyzed. Latent intent topics were identified using non-negative matrix factorization. Interactions were labeled as resolved or unresolved using rule-based heuristics. Logistic regression models with TF-IDF features and conversation-level metadata were evaluated using 5-fold cross-validation. Early-warning models were restricted to the first one or two user messages. Kaplan–Meier analysis was used to assess time-to-unresolved outcomes. Results: Reported side effects were predominantly dermatologic and generally moderate in severity but lacked specificity regarding treatment, dosage, and duration. Machine learning models demonstrated moderate predictive performance (ROC-AUC ≈ 0.72), improving to ≈0.78 using the first two user messages. Unresolved interactions were most likely to occur within the first 3–5 conversational turns. Conclusion: Dermatology chatbots capture valuable patient-reported signals but lack structured data for clinical interpretation. Early detection of unresolved interactions using machine learning is feasible and may support real-time intervention and improved patient safety.

References 

  • 1.

    Esteva, A.; Kuprel, B.; Novoa, R.A.; et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature 2017, 542, 115–118.

  • 2.

    Laranjo, L.; Dunn, A.G.; Tong, H.L.; et al. Conversational agents in healthcare: a systematic review. J. Am. Med. Inform. Assoc. 2018, 25, 1248–1258.

  • 3.

    Miner, A.S.; Laranjo, L.; Kocaballi, A.B. Chatbots in the fight against the COVID-19 pandemic. NPJ Digit. Med. 2020, 3, 65.

  • 4.

    Rajkomar, A.; Dean, J.; Kohane, I. Machine learning in medicine. N. Engl. J. Med. 2019, 380, 1347–1358.

  • 5.

    Topol, E.J. High-performance medicine: the convergence of human and artificial intelligence. Nat. Med. 2019, 25, 44–56.

  • 6.

    Liu, X.; Faes, L.; Kale, A.U.; et al. A comparison of deep learning performance against healthcare professionals. Lancet Digit. Health 2019, 1, e271–e297.

Share this article:
How to Cite
Emam, S.; Gniadecki, R. Patient-Reported Adverse Reactions and Early Detection of Unresolved Interactions in a Canadian Dermatology Chatbot. Dermatology and Skin Science 2026, 1 (1), 4.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.